[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"alzheimer-disease-and-related-dementias-adrd\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:alzheimer-disease-and-related-dementias-adrd":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,44,71],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":30,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100524755","otc-hearing-aid-and-mci-100524755",false,"NCT06112860","OTC Hearing Aid and MCI","Over-the-counter Hearing Aids and Mild Cognitive Impairment","Inclusion Criteria:\n\n* Over 60 years of age\n* Mild dementia or mild cognitive impairment. Diagnosis will be made at participating memory evaluation centers (see recruitment).\n* Mild to moderate bilateral hearing loss and no current hearing aid use.\n* A communication partner who is able and willing to participate in the study.\n* No vision impairment that would interfere with the ability to complete study tasks (i.e., legally blind, severe cataracts, or macular degeneration)\n* Able to provide own consent as evaluated by the Consent Assessment\n\nExclusion Criteria:\n\n1. Clinically significant unstable or progressive medical conditions, or conditions which, in the opinion of the investigator(s) places the participant at unacceptable risk if he or she were to participate in the study.\n2. History of unresolved communication difficulties following another neurological problem (i.e., stroke or brain tumor), neurodevelopmental disorder (i.e., Down's syndrome), or head\u002Fneck cancer\n3. Positive history of major psychiatric disorder (i.e., schizophrenia, significant untreated depression)\n4. Co-enrolled in other intervention studies targeting hearing, language, or communication strategies.\n5. History or current fluctuating hearing loss","ALL","60 Years","90 Years",{"count":20,"type":21},50,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this study is to better understand if, in patients with mild to moderate hearing loss who are also experiencing mild cognitive impairment (MCI) or Alzheimer's disease and related dementias (ADRD), Over-the-Counter (OTC) hearing aids:\n\n1. improve communication\n2. Whether the magnitude of benefit depends on the patient's level of cognitive disability,\n3. Whether alternative remediation (such as targeted communication strategies) offer similar benefits.\n\nParticipants and a communication partner will be randomized into an OTC first or Communication Strategies first arm, where participants will receive communication strategy information customized for those with cognitive impairment.",[27,28,29],"Hearing Loss","Mild Cognitive Impairment","Alzheimer Disease and Related Dementias (ADRD)",[31],"Over-the-counter Hearing Aids","RECRUITING","2026-08-12",{"date":35,"type":36},"2026-08-14","ACTUAL",{"date":38,"type":36},"2024-07-23",{"date":40,"type":21},"2027-03-30",{"name":42,"class":43},"Northwestern University","OTHER",{"id":45,"slug":46,"hasResults":11,"nctId":47,"briefTitle":48,"officialTitle":49,"acronym":4,"eligibilityCriteria":50,"healthyVolunteers":51,"sex":16,"minAge":52,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":22,"phases":55,"briefSummary":56,"conditions":57,"keywords":58,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":70},"100575041","supplementing-neuro-energy-to-aid-cognition-100575041","NCT06767124","Supplementing Neuro-Energy to Aid Cognition","Simultaneous PET\u002FMR Imaging of Brain Glucose and Oxygen Metabolism to Assess Energy Deficits Related to Alzheimer's Disease and the Response to Intervention","Inclusion Criteria - Healthy Participants: Males and females, Age 21 - 80 years, BMI of 18.5-30\n\nInclusion Criteria - Alzheimer's Disease Participants: Positive amyloid and tau biomarkers (as noted by PET imaging, cerebrospinal fluid or blood), Mild cognitive impairment or mild-to-moderate dementia, BMI of 18.5-30\n\nExclusion Criteria: Contraindications to MRI (claustrophobia, metal implants, pacemakers, etc.), Pregnant or breastfeeding women, Neurological disease (healthy participants only), Mental illness, Overt cardio- or neurovascular disease, Recent participation in any procedure(s) involving radioactive agents",true,"21 Years",{"count":54,"type":21},17,[24],"It is projected that by 2030, one in every five Americans will be of retirement age, and this demographic shift is expected to result in more people suffering from dementia. A key feature of the brain is its need for a constant supply of glucose and oxygen to meet the high energy costs of mental activity. This study aims to develop clinically practical, noninvasive imaging methods based on combined positron emission tomography and magnetic resonance imaging to assess brain energy in order to better understand how this critical component of brain health is impacted by aging.",[29],[59],"PET\u002FMR, Keytone Supplement, Brain Energy Metabolism","NOT_YET_RECRUITING","2026-07-27",{"date":63,"type":36},"2026-07-28",{"date":65,"type":21},"2026-09-01",{"date":67,"type":21},"2028-05",{"name":69,"class":43},"University of Pennsylvania",1,{"id":72,"slug":73,"hasResults":11,"nctId":74,"briefTitle":75,"officialTitle":75,"acronym":4,"eligibilityCriteria":76,"healthyVolunteers":51,"sex":16,"minAge":77,"maxAge":4,"enrollmentInfo":78,"targetDuration":4,"studyType":22,"phases":80,"briefSummary":81,"conditions":82,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":84,"lastUpdatePostDateStruct":85,"startDateStruct":87,"completionDateStruct":89,"leadSponsor":91,"locationsCount":70},"100602195","remote-sensing-for-adrd-specific-activities-identification-in-older-adults-100602195","NCT07120347","Remote Sensing for ADRD-Specific Activities Identification in Older Adults","Inclusion Criteria\n\n* Community-dwelling, English-speaking adults aged ≥ 50 years\n* Clinical diagnosis of mild cognitive impairment or mild dementia (ADRD)\n* Diagnosis established by a neuropsychologist, neurologist, or geriatrician within the University of Missouri Healthcare System\n* Diagnosis confirmed using the latest consensus criteria and verified through record review\n* No restriction on the etiology of the cognitive disorder (e.g., Alzheimer's disease, vascular dementia, mixed dementia)\n\nExclusion Criteria\n\n* Clinical Dementia Rating (CDR) global score \\> 1 (moderate or severe dementia)\n* Cognitive or functional impairments that would preclude meaningful participation in daily activities","50 Years",{"count":79,"type":21},16,[24],"The investigators aim to use smart-home sensors and artificial intelligence (AI) to monitor and detect Alzheimer's Disease and Related Dementias (ADRD)-specific daily activities among older adults, with the goal of early symptom detection and personalized support. Dementia, which impacts memory and cognition, remains a global concern. In the United States, more than 6.7 million individuals aged 65 and older are living with ADRD, and projected annual healthcare costs are expected to reach $1 trillion by 2050. This underscores the need for deeper understanding and innovative support. To address the unique challenges associated with ADRD, such as cognitive decline, personalized strategies that promote independent well-being are essential. Smart-home sensors can support older adults with ADRD as they continue to live in their homes. These sensors provide real-time data on health and daily activities, offering insights into their daily lives. However, adoption of these technologies is low, and the practical application of AI remains limited. This highlights the need for further research to make these devices more accessible to this population. The investigators' aims include:\n\nConducting focus groups with individuals with and without ADRD and their caregivers to identify daily activities that can be measured using in-home sensors; Collecting in-home sensor data from older adults with and without ADRD; and Using AI to develop a tool for recognizing daily activities. The integration of smart-home sensors with advanced data-analysis techniques holds significant potential for transforming the support and care provided to individuals with ADRD. Ultimately, the investigators' findings will contribute to improving the quality of life for affected individuals and alleviating the burden on caregivers and healthcare systems.",[29,83],"Mild Cognitive Impairment (MCI)","2025-08-06",{"date":86,"type":36},"2025-08-13",{"date":88,"type":36},"2024-08-01",{"date":90,"type":21},"2027-07-31",{"name":92,"class":43},"University of Missouri-Columbia"]